A specialty biopharmaceutical business focused on therapies for men’s health and connective tissue disorders, best known for developing the injectable biologic Xiaflex used to treat Dupuytren’s contracture and Peyronie’s disease. The company built its portfolio around urology and orthopedics, combin...
No congressional trades have been disclosed for 34697 (AUXL) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
No congressional trades found for this stock.